Total Payments
$8,046
2024 Payments
$688.37
Companies
35
Transactions
350
Medicare Patients
1,161
Medicare Billing
$186,176
Payment Breakdown by Category
Food & Beverage$7,899 (98.2%)
Education$146.35 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,899 | 346 | 98.2% |
| Education | $146.35 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,304 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $872.08 | 45 | $0 (2024) |
| PFIZER INC. | $702.71 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $672.04 | 31 | $0 (2024) |
| ABBVIE INC. | $570.85 | 23 | $0 (2024) |
| UCB, Inc. | $535.11 | 22 | $0 (2023) |
| Lilly USA, LLC | $455.63 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $436.65 | 18 | $0 (2024) |
| Genentech USA, Inc. | $412.41 | 20 | $0 (2019) |
| Mallinckrodt Hospital Products Inc. | $275.66 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $688.37 | 28 | AstraZeneca Pharmaceuticals LP ($129.25) |
| 2023 | $898.90 | 37 | Novartis Pharmaceuticals Corporation ($187.43) |
| 2022 | $1,081 | 47 | UCB, Inc. ($216.71) |
| 2021 | $1,260 | 56 | PFIZER INC. ($201.06) |
| 2020 | $841.28 | 34 | PFIZER INC. ($206.63) |
| 2019 | $1,023 | 43 | Amgen Inc. ($323.41) |
| 2018 | $951.64 | 46 | Amgen Inc. ($364.24) |
| 2017 | $1,302 | 59 | Janssen Biotech, Inc. ($171.03) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Respiratory | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Dermatology | ||||||
| 09/10/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | Zimmer Biomet Holdings, Inc. | — | Food and Beverage | In-kind items and services | $16.85 | General |
| 08/02/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | Zimmer Biomet Holdings, Inc. | VISCO-3 sodium hyaluronate (Device) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Knees | ||||||
| 07/25/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Respiratory | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Dermatology | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Respiratory | ||||||
| 05/30/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: IMMUNOLOGY | ||||||
| 05/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological), NUCALA | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Respiratory | ||||||
| 03/28/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: Inflammation | ||||||
| 03/21/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Immunology | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 243 | 538 | $189,110 | $50,091 |
| 2022 | 3 | 250 | 581 | $197,810 | $50,017 |
| 2021 | 4 | 288 | 587 | $189,750 | $49,051 |
| 2020 | 7 | 380 | 629 | $176,193 | $37,018 |
Total Patients
1,161
Total Services
2,335
Medicare Billing
$186,176
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 369 | $114,750 | $29,429 | 25.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 95 | 169 | $74,360 | $20,662 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 467 | $146,450 | $36,173 | 24.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 99 | $43,560 | $12,042 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $7,800 | $1,802 | 23.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 457 | $142,130 | $37,340 | 26.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 63 | $27,720 | $7,992 | 28.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 54 | $13,140 | $2,360 | 18.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $6,760 | $1,358 | 20.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 178 | 376 | $116,800 | $23,048 | 19.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 99 | $23,580 | $4,059 | 17.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 77 | 83 | $6,213 | $3,591 | 57.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 18 | $9,720 | $2,255 | 23.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $8,840 | $1,794 | 20.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 14 | 25 | $7,500 | $1,679 | 22.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $3,540 | $591.27 | 16.7% |
About Dr. Eddys Disla, M.D
Dr. Eddys Disla, M.D is a Rheumatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679619233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eddys Disla, M.D has received a total of $8,046 in payments from pharmaceutical and medical device companies, with $688.37 received in 2024. These payments were reported across 350 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($7,899).
As a Medicare-enrolled provider, Disla has provided services to 1,161 Medicare beneficiaries, totaling 2,335 services with total Medicare billing of $186,176. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location New York, NY
- Active Since 01/30/2007
- Last Updated 04/17/2019
- Taxonomy Code 207RR0500X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679619233
Products in Payments
- Enbrel (Biological) $731.72
- XELJANZ (Drug) $702.71
- Cimzia (Drug) $535.11
- COSENTYX (Biological) $517.07
- TALTZ (Drug) $420.75
- ACTHAR (Biological) $417.84
- BENLYSTA (Biological) $396.05
- RINVOQ (Biological) $368.78
- Rituxan (Biological) $358.87
- EVENITY (Biological) $348.95
- COSENTYX (Drug) $307.11
- FARXIGA (Drug) $258.81
- SYMBICORT (Drug) $239.97
- SIMPONI ARIA (Biological) $209.75
- XARELTO (Drug) $148.89
- KRYSTEXXA (Biological) $148.85
- NAMENDA XR (Drug) $95.37
- OFEV (Drug) $82.59
- BREZTRI (Drug) $81.85
- ORENCIA (Biological) $74.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in New York
Laurie Glimcher, Md, MD
Rheumatology — Payments: $8.3M
Rheumatology $8.3M
Dr. Grace Wright, Md, MD
Rheumatology — Payments: $3.7M
Rheumatology $3.7M
Sergio Schwartzman, M.d, M.D
Rheumatology — Payments: $3.5M
Rheumatology $3.5M
Dr. Allan Gibofsky, Md, MD
Rheumatology — Payments: $2.4M
Rheumatology $2.4M
Petros Efthimiou, Md, MD
Rheumatology — Payments: $1.2M
Rheumatology $1.2M
Dr. Olga Petryna, Md, MD
Rheumatology — Payments: $548,960
Rheumatology $548,960